Copyright
©The Author(s) 2021.
World J Hepatol. Jun 27, 2021; 13(6): 673-685
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.673
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.673
Figure 2 Donor-specific antibody presences on graft survival.
Kaplan-Meyer survival plot; vertical axis: Graft survival (decimal); horizontal axis: Time of graft survival (months); graphs: Donor-specific antibody (DSA)-negative patients are shown in dark grey, numbers at risk n = 34; DSA-positive patients are shown in green, numbers at risk n = 38. DSA: Donor-specific antibody.
- Citation: Schotters FL, Beime J, Briem-Richter A, Binder T, Herden U, Grabhorn EF. Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation. World J Hepatol 2021; 13(6): 673-685
- URL: https://www.wjgnet.com/1948-5182/full/v13/i6/673.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i6.673